The decision to participate in a clinical trial is a complex and deeply personal one, influenced by a myriad of factors. Patients and their families must navigate a landscape filled with medical, emotional, and logistical considerations. This article delves into the various challenges and
The nomination of Robert F. Kennedy Jr. as the Health and Human Services Secretary has sparked significant controversy, primarily due to his well-documented skepticism towards vaccines. This stance has alarmed many medical professionals, public health advocates, and influential figures who view his
Imagine a technology capable of identifying 'fresh' blood clots in real time within patients suffering from peripheral artery disease (PAD), promising to revolutionize treatment and patient outcomes. This is precisely what Sensome's Clotild Smart Guidewire System aims to achieve, combining
The recent FDA approval of Johnson & Johnson (J&J) MedTech’s Impella 5.5 with SmartAssist and Impella CP with SmartAssist heart pumps for pediatric use marks a significant milestone in pediatric cardiac care. This development opens new avenues for treating children with acute decompensated heart
Randomization in clinical trials is essential for reducing selection bias among participants and ensuring robust and reliable results. Solventum, a leading medical device company, has revolutionized this vital process by utilizing the Zelta by Merative eClinical platform, introducing an innovative
FemPulse has recently achieved a significant milestone by obtaining an investigational device exemption (IDE) from the US Food and Drug Administration (FDA). This approval allows the company to conduct a pivotal clinical trial for its neuromodulation system designed to treat overactive bladder
